Company Filing History:
Years Active: 2018
Title: Tzu-Chi Lou: Innovator in Lipid Metabolism
Introduction
Tzu-Chi Lou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of lipid metabolism. His innovative work focuses on developing solutions for hyperlipidemia treatment.
Latest Patents
Tzu-Chi Lou holds a patent for the use of GMNL-263 in decreasing blood lipid levels. This patent discloses that GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factors and lipid synthesis. Additionally, it promotes gene expression related to cholesterol metabolism. The application of GMNL-263 is aimed at producing a composition that effectively decreases blood lipid levels, thereby addressing hyperlipidemia.
Career Highlights
Tzu-Chi Lou is associated with Genmont Biotech Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on health and wellness.
Collaborations
Some of his notable coworkers include Yi-Hsing Chen and Ya-Hui Chen, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Tzu-Chi Lou's innovative work in lipid metabolism and his patent on GMNL-263 highlight his commitment to addressing health challenges related to hyperlipidemia. His contributions are paving the way for advancements in biotechnology and therapeutic solutions.